Loading clinical trials...
Loading clinical trials...
This is a prospective, multicenter, observational study of kidney transplant subjects where blood specimens, intended for dd-cfDNA and other future research purposes, will be drawn after transplant
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
CareDx
NCT05702398 · Skin Cancer, Kidney Transplant Recipients
NCT06806670 · Kidney Transplant Recipients
NCT05938712 · Kidney Transplant Recipients
NCT02555566 · Kidney Transplant Recipients
NCT04965935 · Kidney Transplant Recipients, Post-transplant Diabetes Mellitus, and more
University of Alabama, Birmingham
Birmingham, Alabama
University of California Los Angeles
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions